µTASWako™ DCP Test

µTASWako™ DCP Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).

Product information

µTASWako™ DCP Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).

DCP (des-gamma-carboxy prothrombin) is an immature form of the coagulation protein, prothrombin. In the normal metabolism the prothrombin precursor undergoes a vitamin K dependent of carboxylation of 10 glutamicacid residues at the N-terminus to yield the native prothrombin. In the case of HCC, this transformation is impaired, which results in an accumulation of DCP. DCP is also known as protein induced by vitamin K absence or antagonist II (PIVKA-II).

µTASWako™ DCP Test allows an early diagnosis of HCC and is run on the µTASWako™ i30 device.

All test components are CE-certified.

Click here for more information for Health Care Providers.

Key Features

CE-marked in vitro diagnostic test
Superior specificity for HCC

Storage

Store at 2-10° C.

Safety Information

Health Hazard

Serious Health Hazard

Corrosive

Literature

For more information and the latest publications please visit Videos & Publications.

Ordering information

Name	Volume	Article number
μTASWako DCP	1 cartridge (100 tests)	995-60701
μTASWako DCP Calibrator	1 set	999-61201
μTASWako DCP Control L	4 x 2 ml	995-61301
μTASWako DCP Control H	4 x 2 ml	991-61401
μTASWako Wash Solution	4 x 60 ml	991-60801
μTASWako Sample Cup S	1000 units	452-00501
μTASWako Printer Paper	1 unit	991-60811
μTASWako Chip Cassette	5 x 20 units	993-61601
μTASWakoTM i30 Analyzer	1 unit	991-60301